Clinical Trial Update: Study of Difluprednate in the Treatment of Inflammation Following Ocular Surgery (ST-601-003) [Phase 3]

View source ↗

Summary

A Phase 3 study evaluating difluprednate for treating ocular inflammation after surgery has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Inflammation
• Postoperative Inflammation

Drugs mentioned

• Durezol (difluprednate)

Snippet

Sponsor: Sirion Therapeutics, Inc. | Conditions: Inflammation | Phase 3 | Status: COMPLETED